Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product ...

Boston Scientific (NYSE:BSX – Get Free Report) had its price target upped by equities researchers at Canaccord Genuity Group from $98.00 to $101.00 in a research report issued on Monday,Benzinga ...

Mindanao's longest-running community newspaper ...